rVSVΔG-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire Glycoprotein: Standardized template with key considerations for a risk/benefit assessment

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. A recent publication by the V3SWG described live, attenuated, recombinant vesicular stomatitis virus (rVSV) as a chimeric vi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine X
Main Authors: Monath, Thomas P., Fast, Patricia E., Modjarrad, Kayvon, Clarke, David K., Martin, Brian K., Fusco, Joan, Nichols, Richard, Heppner, D. Gray, Simon, Jakub K., Dubey, Sheri, Troth, Sean P., Wolf, Jayanthi, Singh, Vidisha, Coller, Beth-Ann, Robertson, James S.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Brighton Collaboration
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668225/
https://ncbi.nlm.nih.gov/pubmed/31384731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados